Pharmaceutical Technology

MAY 25, 2023

The Medicines and Healthcare products Regulatory Agency (MHRA) aims to launch a pilot genetic biobank that will gather patient data to associate drug-related adverse events to their genetic makeup. The Yellow Card biobank will launch as a joint venture with the UK-government funded entity Genomics England on June 1.

Biobanking 130

Biobanking Genetics Genome Project Genome 130

Scienmag

NOVEMBER 25, 2020

Researchers from the 10+ Wheat Genomes Project, led by Professor Curtis Pozniak (University […].

Genomics 52

Genomics Genome Genome Project Genetics 52

Pharmaceutical Technology

SEPTEMBER 15, 2022

From the Human Genome Project to contemporary drug development, collaboration is critical to the life sciences. They are where innovative companies can look to access research and tap into networks, cross-pollinating ideas and talent and testing products to accelerate development. Structured for business.

Life Science 130

Life Science Drug Delivery Genome Project Development 130

Scienmag

JANUARY 17, 2022

A global effort to map the genomes of all plants, animals, fungi and other microbial life on Earth, is entering a new phase as it moves from pilot projects to full-scale production sequencing. This new phase of the The Earth BioGenome Project, or EBP, is marked with a collection of papers published this week (Jan. […].

Genomics 84

Genomics Genome Production Genome Project 84

The Pharma Data

APRIL 6, 2021

and European Union (EU) approvals, will also be presented, including long-term outcomes in patients with TRK fusion cancer receiving larotrectinib and data from the 100,000 Genomes Project analyzing the prognostic factor for survival for patients with tumors that harbor a neurotrophic receptor tyrosine kinase ( NTRK ) gene fusion.

Research 52

Research Genome Project Gene Genomics 52

Roots Analysis

AUGUST 28, 2022

Examples of recently signed commercialization deals include (in reverse chronological order) collaboration between S2 Genomics and Mission Bio (April 2022), Ultivue and Standard BioTools (August 2021), 10x Genomics and Advanced Genomics Core (October 2020). The trend is unlikely to change in the foreseen future.

Genomics 52

Genomics Genome RNA Genome Project 52

pharmaphorum

APRIL 20, 2022

As a result, the advancement in genetic sequencing, powered by programs such as The Cancer Genome Atlas and the 100,000 Genomes Project, has led to a greater understanding of the genes that have direct implications in the causes of cancer. CRISPR Therapeutics is one company that is taking this approach.

Gene Editing 52

Gene Editing DNA Gene Genetics 52